Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/24/1996 | US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells |
09/24/1996 | US5559010 Nutrient regulated gene expression systems |
09/24/1996 | US5559009 Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins |
09/24/1996 | US5559008 Dna sequences, codes, gene expression, vectors |
09/24/1996 | US5559007 Secretion of hirudin from host cell, gene expression, major secretion product of lactococcus |
09/24/1996 | US5559005 Bioprocess for preparing 7-ACA and 7-ADAC |
09/24/1996 | US5559000 Encoded reaction cassette |
09/24/1996 | US5558999 Genetic engineering |
09/24/1996 | US5558997 Monoclonal antibodies to mycosphaerella species |
09/24/1996 | US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof |
09/24/1996 | US5558992 Detection of synthetic oligonucleotides extracted from body fluids or tissues |
09/24/1996 | US5558991 DNA sequencing method using acyclonucleoside triphosphates |
09/24/1996 | US5558989 Nucleic acid probes for the detection of Giardia lamblia |
09/24/1996 | US5558867 Poultry |
09/24/1996 | US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies |
09/24/1996 | US5558862 Method of controlling insects |
09/24/1996 | US5558860 Viral vaccines |
09/24/1996 | CA2172447A1 Dna molecules for expression of polypeptides |
09/24/1996 | CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells |
09/24/1996 | CA2172315A1 Gene participating in the mechanism of secretion of esterase |
09/24/1996 | CA1338605C Gene encoding insecticidal protein and production of said protein using said gene |
09/22/1996 | CA2172325A1 Apoptosis-regulating proteins |
09/19/1996 | WO1996028730A1 Method of identifying molecules that regulate fgf activity |
09/19/1996 | WO1996028571A1 Method for the qualitative and quantitative detection of dna damage |
09/19/1996 | WO1996028569A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same |
09/19/1996 | WO1996028566A2 Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis |
09/19/1996 | WO1996028565A1 Novel gene recombinant |
09/19/1996 | WO1996028564A1 Novel recombinant dna vectors for gene therapy |
09/19/1996 | WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
09/19/1996 | WO1996028562A2 Method of checking undesired multiplication of viruses and of preparing virus-resistant organisms |
09/19/1996 | WO1996028561A1 Chimeric genes comprising a fungus-responsive element |
09/19/1996 | WO1996028560A1 Novel cell strains |
09/19/1996 | WO1996028559A1 Method for the production of cationic peptides |
09/19/1996 | WO1996028558A1 Thermitase variants having decreased adsorption and increased hydrolysis |
09/19/1996 | WO1996028557A2 Subtilisin dy variants having decreased adsorption and increased hydrolysis |
09/19/1996 | WO1996028556A2 Proteinase k variants having decreased adsorption and increased hydrolysis |
09/19/1996 | WO1996028555A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
09/19/1996 | WO1996028554A1 Dna encoding protein kinase |
09/19/1996 | WO1996028553A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
09/19/1996 | WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2 |
09/19/1996 | WO1996028551A1 Vaccines for plague |
09/19/1996 | WO1996028550A1 Human restrictin and nucleic acid sequences |
09/19/1996 | WO1996028549A2 Hyaluronan receptor expressed in human umbilical vein endothelial cells |
09/19/1996 | WO1996028548A1 Receptor activation by gas6 |
09/19/1996 | WO1996028547A1 Dermatomyositis-specific auto-antigen |
09/19/1996 | WO1996028546A1 Human tumor necrosis factor receptor |
09/19/1996 | WO1996028545A1 Dna strand useful in increasing carotenoid yield |
09/19/1996 | WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
09/19/1996 | WO1996028542A1 An enzyme with aminopeptidase activity |
09/19/1996 | WO1996028474A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels |
09/19/1996 | WO1996028472A1 Antigen composition against mycoplasma |
09/19/1996 | WO1996028461A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
09/19/1996 | WO1996028460A1 C-nucleoside derivatives and their use in nucleic acid detection |
09/19/1996 | WO1996028457A1 Nucleic acid synthesis using photoremovable protecting groups |
09/19/1996 | WO1996028189A1 A double transdominant fusion gene and protein |
09/19/1996 | WO1996028183A1 Method for treatment of autoimmune diseases using interferon-tau |
09/19/1996 | WO1996028014A1 Lycopene cyclase gene |
09/19/1996 | WO1996022372A3 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
09/19/1996 | WO1996019587A3 Methods of immobilizing oligonucleotides to solid support materials and methods of using support bound oligonucleotides |
09/19/1996 | WO1996018736A3 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
09/19/1996 | WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
09/19/1996 | WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage |
09/19/1996 | WO1995014774A3 Toxicity-resistant molasses gene, related products and use thereof for the analysis and enhancement of microorganisms and molasses |
09/19/1996 | DE4090006C2 Purified sciatic nerve ciliary neurotrophic factor |
09/19/1996 | DE19509038A1 C-Nukleosid-Derivate und deren Verwendung in der Detektion von Nukleinsäuren C-nucleoside derivatives and their use in the detection of nucleic acids |
09/19/1996 | CA2215657A1 Nucleic acid synthesis using photoremovable protecting groups |
09/19/1996 | CA2215493A1 Method for the qualitative and quantitative detection of dna damage |
09/19/1996 | CA2215391A1 Method of identifying molecules that regulate fgf activity |
09/19/1996 | CA2215383A1 Human tumor necrosis factor receptor |
09/19/1996 | CA2215362A1 Method for the production of cationic peptides |
09/19/1996 | CA2215357A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels |
09/19/1996 | CA2215260A1 Dna encoding protein kinase |
09/19/1996 | CA2215016A1 Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof |
09/19/1996 | CA2214995A1 Hyaluronan receptor expressed in human umbilical vein endothelial cells |
09/19/1996 | CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
09/19/1996 | CA2214578A1 Thermitase variants having decreased adsorption and increased hydrolysis |
09/19/1996 | CA2214490A1 Method for treatment of autoimmune diseases using interferon-tau |
09/19/1996 | CA2214469A1 Lycopene cyclase gene |
09/19/1996 | CA2214010A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
09/19/1996 | CA2189361A1 Chimeric genes comprising a fungus-responsive element |
09/19/1996 | CA2189252A1 Human restrictin and nucleic acid sequences |
09/18/1996 | EP0732409A2 Detection of human tumor progression and drug resistance |
09/18/1996 | EP0732408A2 Nucleic acid probes for the detection of chlamidia trachomatis |
09/18/1996 | EP0732405A1 Recombinant DNA virus and method for preparation thereof |
09/18/1996 | EP0732404A1 Novel expression screening vector |
09/18/1996 | EP0732403A1 Yeast expression systems with vectors having GAPDH promoters, and synthesis of HBsAg |
09/18/1996 | EP0732402A2 Chimeric chains for receptor-associated signal transduction pathways |
09/18/1996 | EP0732401A2 Megakaryocyte stimulating factor (meg-CSF) |
09/18/1996 | EP0732398A1 Novel tyrosine kinase |
09/18/1996 | EP0732397A2 Modified hepatocytes and uses therefor |
09/18/1996 | EP0732340A2 Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
09/18/1996 | EP0732104A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able to produce such particles and process for their obtention |
09/18/1996 | EP0731848A1 Solution phase nucleic acid sandwich assays having reduced background noise |
09/18/1996 | EP0731846A1 Nucleoside analogue method |
09/18/1996 | EP0731845A1 Homologous recombination antibody expression system for murine cells |
09/18/1996 | EP0731844A1 Promoter |
09/18/1996 | EP0731843A1 Tyrosinase-activator protein fusion enzyme |
09/18/1996 | EP0731842A1 Recombinant binding proteins and peptides |
09/18/1996 | EP0731841A1 Proteases from streptomyces and use thereof in protein expression systems |
09/18/1996 | EP0731840A1 Nucleic acid sequences encoding a plant cytoplasmic protein involved in fatty acyl-coa metabolism |